Results 141 to 150 of about 112,202 (290)

Trial watch: beta-blockers in cancer therapy. [PDF]

Oncoimmunology, 2023
Carnet Le Provost K, Kepp O, Kroemer G, Bezu L.   +3 more
europepmc   +1 more source

Beta-Adrenergic Blocking Action of Ruthenium Red

, 1973
Akira Tomiyama, Issei TAKAYANAGI, Masaki Saeki, Keijiro Takagi   +3 more
openalex   +1 more source

A Comparison of Beta-Blocking Agents [PDF]

, 1973
Robert E. Goldstein
openalex   +1 more source

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS

Российский кардиологический журнал, 2009
The paper presents modern views on beta-blocker therapy in clinical practice. The beta-blocker group is heterogeneous in terms of clinical usage.
D. V. Nebieridze, R. G. Kulieva, V. D. Sargsyan, N. L. Vinnitskaya   +3 more
doaj  

Metabolic Fate of Carteolol Hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3, 4-dihydrocarbostyril Hydrochloride, OPC-1085], a New β-Blocker. V. Identification of Metabolites in Rat, Dog and Human

, 1977
Hideo Mori, MASARU KIDO, Nanami Murakami, Seiji Morita, Hideaki Kohri, KAZUYUKI NAKAGAWA, Toshiyuki Uno, Takafumi Ishihara   +7 more
openalex   +2 more sources

Pharmacokinetics of the new beta‐adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings] [PDF]

, 1979
G. Bianchetti, C Blatrix, Roberto Goméni, JR Kilborn, J Larribaud, P W Lücker, Morselli Pl, J.J Thebault, Suzanne Trocherie   +8 more
openalex   +1 more source

Potential effects of beta-blockers in HFpEF. [PDF]

Heart Fail Rev
Tokarczyk W, Urban S, Patrzałek P, Stolarski Ł, Iwanek G, Szymański O, Zymliński R.   +6 more
europepmc   +1 more source

Raynaud's phenomenon as side effect of beta-blockers in hypertension. [PDF]

, 1976
A. Marshall, CJ Roberts, D W Barritt
openalex   +1 more source

Beta blockers? [PDF]

Nature, 2008
openaire   +2 more sources

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Several genetic loci known to confer risk for Parkinson's disease (PD) function in lysosomal pathways. We systematically screened common variants linked to PD risk by genome‐wide association studies (GWAS) for impact on cerebrospinal fluid (CSF) proteins reflecting lysosomal function.
Hanwen Zhang, Daniel Kargilis, Thomas Tropea, John Robinson, Junchao Shen, Eliza M. Brody, Ann Brinkmalm, Simon Sjödin, Adama J. Berndt, Marc Carceles‐Cordon, EunRan Suh, Vivianna M. Van Deerlin, Kaj Blennow, Daniel Weintraub, Edward B. Lee, Henrik Zetterberg, Alice S. Chen‐Plotkin   +16 more
wiley   +1 more source